4.6 Editorial Material

Trials and Tribulations of EGFR and MET Inhibitor Combination Therapy in NSCLC

Journal

JOURNAL OF THORACIC ONCOLOGY
Volume 12, Issue 1, Pages 9-11

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jtho.2016.11.2214

Keywords

-

Funding

  1. Pfizer
  2. Novartis
  3. Roche Genentech
  4. AstraZeneca

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available